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Oxidative Stress by Monoamine Oxidase Mediates
Receptor-Independent Cardiomyocyte Apoptosis by
Serotonin and Postischemic Myocardial Injury
Pascale Bianchi, PhD; Oxana Kunduzova, PhD; Emanuela Masini, MD; Claudie Cambon, PhD;
Daniele Bani, MD; Laura Raimondi, PharmD; Marie-Helene Seguelas, BSc; Silvia Nistri, PhD;
Wilson Colucci, MD; Nathalie Leducq, PhD; Angelo Parini, MD, PhD
Background—Serotonin (5-hydroxytryptamine [5-HT]), released by activated platelets during cardiac ischemia, is
metabolized by the mitochondrial enzyme monoamine oxidase A (MAO-A). Because hydrogen peroxide is one of the
byproducts of 5-HT degradation by MAO-A, we investigated the potential role of reactive oxygen species generated by
MAOs in 5-HT–dependent cardiomyocyte death and post–ischemia-reperfusion cardiac damage.
Methods and Results—Treatment of isolated adult rat cardiomyocytes with 5-HT induced intracellular oxidative stress and
cell apoptosis. The apoptotic cascade triggered by 5-HT involves release of cytochrome c, upregulation of proapoptotic
Bax protein, and downregulation of antiapoptotic Bcl-2 protein. These effects were prevented by inhibition of amine
transporter or MAO, antioxidants, or iron chelation. In contrast, cardiomyocyte apoptosis was only slightly affected by
the 5-HT2B receptor antagonist SB 206553. In vivo, inhibition of MAO-A largely reduced myocardial ultrastructural
damage induced by 30 minutes of ischemia followed by 60 minutes of reperfusion in the rat heart. Cardioprotective
effects of MAO inhibitors were associated with the prevention of postischemic oxidative stress, neutrophil accumula-
tion, and mitochondrial-dependent cell death and were not reverted by SB 206553. Administration of MAO-A inhibitors
during ischemia was still effective in preventing cardiac damage.
Conclusions—Our results supply the first direct evidence that oxidative stress induced by MAO is responsible for
receptor-independent apoptotic effects of 5-HT in cardiomyocytes and postischemic myocardial injury. These findings
provide new insight into the mechanisms of 5-HT action in the heart and may constitute the basis for novel therapies.
(Circulation. 2005;112:3297-3305.)
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Serotonin (5-HT) is a biogenic amine produced in thecentral nervous system by cells originating in the raphe
nuclei of the brainstem. In periphery, serotonin is produced
predominantly by intestinal enterochromafin cells and stored
in platelets. Serotonin affects a wide variety of physiological
functions through the interaction with specific G-coupled
membrane receptors. In the heart, 5-HT has been involved in
regulation of normal cardiac development1 and in different
diseases, including arrhythmia,2 ventricular hypertrophy,3
and cardiac valvular insufficiency associated with carcinoid
tumors.4 During the last years, several studies showed that
serotonin accumulates in heart during ischemia-reperfusion
(I/R) and contributes to the progression of myocardial injury
and dysfunction.5–7 The deleterious effects of serotonin have
been related to indirect mechanisms involving coronary
vasoconstriction8 and reactive oxygen species (ROS)–depen-
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dent stimulation of cardiac sympathetic afferents.5,9 At present, the
possibility that serotonin acts directly on cardiac cells to induce
apoptosis and necrosis has not been investigated. However, this
possibility is suggested by our recent studies showing that the
serotonin-degrading mitochondrial enzyme monoamine oxidase A
(MAO-A) is an important source of hydrogen peroxide (H2O2) in
the heart.10 Monoamine oxidases are outer mitochondrial mem-
brane enzymes that, based on genetic criteria,11 substrate specificity,
and inhibition by synthetic compounds,12 have been subdivided into
2 major forms, A and B. The degradation of biogenic amines
(serotonin and catecholamines) has been considered the major
physiological function of these enzymes. However, we have re-
cently shown that in kidney H2O2 produced by MAOs during
dopamine degradation mediates cell apoptosis.13 Although heart
contains large amount of MAO-A,14 the role of this enzyme in
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regulation of cardiac functions is still not clearly defined. Some
studies indicated that cardiac MAO-A regulates noradrenaline
concentrations.15,16 Our demonstration that MAO-A is also an
important source of H2O2 in the heart suggests that this enzyme may
contribute to ROS-dependent cardiomyocyte apoptosis. To verify
this hypothesis, we investigated the potential role of ROS generated
by MAO-A during 5-HT degradation in cardiomyocyte death and
the role of MAO in post-I/R cardiac damage.
Methods
Cell Culture
Calcium-tolerant adult rat ventricular myocytes were obtained from hearts
of male Sprague-Dawley rats (250 to 275 g) as previously described.17
Briefly, hearts were perfused retrogradely with Ca2-free Krebs-Henseleit
bicarbonate buffer and dissociated in the same buffer containing 0.02
mg/mL trypsin and 0.02 mg/mL deoxyribonuclease. The cells were filtered
and sedimented through 60 g/mL BSA (Sigma-Aldrich) to separate
ventricular myocytes from nonmyocytes as described by Ellingsen et al.18
The cell pellet was resuspended and plated in ACCT medium consisting of
DMEM containing 2 mg/mL BSA, 2 mmol/L L-carnitine, 5 mmol/L
creatine, 5 mmol/L taurine, 100 IU/mL penicillin, and 100 g/mL
streptomycin.
Evaluation of Apoptosis and Necrosis
In vitro, morphological changes in the nucleus were detected as described
by Meilhac et al.19 Necrosis and apoptosis were evaluated concomitantly on
intact cultured cells after fluorescent staining using vital fluorescent dyes
SYTO-13 (0.6 mol/L), a permeant DNA intercalating green probe, and
propidium iodide (15 mol/L), a nonpermeant intercalating orange probe
(Molecular Probes), and counted with an inverted fluorescence microscope
(Fluovert FU, Leitz). Normal nuclei exhibited loose chromatin colored
green by SYTO-13; apoptotic nuclei exhibited condensed green chromatin;
necrotic cells exhibited orange nuclei with loose chromatin.
In vivo, apoptosis was evaluated with the DeadEnd Fluorometric
TUNEL system according to the manufacturer’s instructions (Pro-
mega). Briefly, the deparaffinized heart sections were incubated in a
20 g/mL proteinase K solution to permeabilize the tissues, rinsed,
and fixed in 4% paraformaldehyde. The sections were then incubated
with terminal deoxynucleotidyl transferase (25 U/L) and fluores-
cein-12-dUTP for 1 hour at 37°C. After rinsing in 1 PBS, the slides
were immersed in propidium iodide solution (1 g/L) for 15
minutes.
TABLE 1. Area at Risk and Infarct Size
LV WT, g Infarct WT, g Infarct % of LV Risk Region WT, g Risk Region % of LV
I/R 0.330.015 0.10.004 29.83.6 0.170.008 522.1
PI/R 0.350.005 0.020.0004* 7.130.47* 0.170.002 47.52
CI/R 0.350.004 0.040.0004* 10.750.25* 0.180.002 501.9
PSBI/R 0.360.012 0.040.001* 11.360.25* 0.180.006 50.51.5
CSBI/R 0.350.0012 0.050.002* 13.771.3* 0.180.006 511.2
LV indicates left ventricular; WT, weight; P, paragyline; C, clorgyline; and SB, SB 206553. Data are meanSEM.
*P0.001 vs I/R.
TABLE 2. Scoring Method of Myocyte and Endothelial Injury
Injury Score Degree of Injury Description
Myocyte 0 Normal myocyte
1 Slight Mild intracellular edema
Mild mitochondrial swelling
2 Moderate Mild intracellular edema
Contracture of myofibrils
Marked mitochondrial swelling with matrix clearing
Occasional foal clumping of mitochondrial cristae
Mild nuclear chromatin clumping
3 Severe Severe mitochondrial swelling with loss of cristae
Presence of intramitochondrial dense granules
Disarrangement of myofibrils
Plasma membrane rupture
Nuclear degeneration (apoptosis or karyolysis)
Endothelial 0 Normal endothelium
1 Slight Mild to moderate endothelial swelling
2 Moderate Marked endothelial swelling
Decreased pinocytic vesicles
Mitochondrial swelling
3 Severe Severe mitochondrial swelling with loss of cristae
Plasma membrane rupture
Nuclear degeneration (apoptosis or karyolysis)
Neutrophil adhesion and extravasation
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Western Blot Analysis
The proteins levels of Bax, Bcl-2, and procaspase-3 were assessed by
immunoblotting on cells and heart lysates. The blot was stripped
completely of antibodies before reprobing with a polyclonal anti-
actin antibody used as a standard. The quantity of proteins loaded
from cardiac myocyte extracts was normalized with Ponceau red.
Caspase-3 Activity
Caspase-3 activity was assess with EnzChek Caspase-3 Assay Kit #1
(Molecular Probes) according to the manufacturer’s instructions. Briefly,
cells were harvested in 1 cell lysis buffer. After centrifugation (5000 rpm
for 5 minutes), the supernatant were transferred to a microplate, and 2
substrate working solution (10 mmol/L Z-DEVD-AMC substrate) was
added. The microplate was incubated in dark at room temperature for 30
minutes. Substrate cleavage was monitored fluorometrically with a Spec-
traMax Gemini spectrophotometer (Molecular Devices) with excitation and
emission wavelengths of 350 and 450 nm.
Hydrogen Peroxide Production
H2O2 production was determined by the oxidation of 2,7-dichlorodihydro-
fluorescein (DCFH) (Molecular Probes) to a fluorescent 2,7-dichlorofluo-
rescein (DCF). DCFH was added to a final concentration of 20 mol/L at
37°C for 30 minutes. After 2 washes, images obtained with an inverted
fluorescence microscope (Fluovert FU, Leitz) were used to quantify
fluorescence intensity with SigmaScan Pro 5 software.
Measurement of the GSH/GSSG Ratio
The ratio between reduced (GSH) and oxidized (GSSG) glutathione
was determined with the Bioxytech GSH/GSSG-412 kit (OxisRe-
search) adapted for cells. Briefly, cells were washed with 1 PBS
and harvested into GSH assay buffer. After homogenization, they
were centrifuged at 10 000g for 15 minutes. Then, 5% metaphos-
phoric acid was added to the supernatant. After centrifugation at
10 000g for 2 minutes, the supernatant was divided into 2 samples,
1 for GSH and 1 for GSSG measures. The assays were performed at
412-nm OD during 3 minutes with a SpectraMax 340 pc spectro-
photometer (Molecular Devices).
Animals
The experimental protocol was designed in compliance with the
recommendations of the European Economic Community (86/609/
CEE) for the care and use of laboratory animals and was approved by
the animal care committee of the University of Florence (Italy). Male
Wistar albino rats weighing 200 to 250 g (Harlan, Milan, Italy) were
anesthetized with intraperitoneal injection of sodium thiopenthal
(Penthotal, Abbott; 50 mg/kg). A cannula was inserted into the
trachea, and the animals were ventilated with air with a Palmer pump
(U. Basile). All rats underwent thoracotomy at the fifth left inter-
costal space, the pericardium was opened, and a loose 5-0 braided
silk suture was placed around the left anterior descending coronary
artery, together with a small silicon ring to permit an easy removal
of the ligature. Ischemia (30 minutes) was induced by tightening the
threads of the coronary suture. Reperfusion (60 minutes) was
obtained by reopening the chest and cutting the ligature around the
coronary artery. In all animals, survival time was recorded.
Experimental Protocol
The protocol included 8 groups of rats treated as follows: Group 1 (n10),
sham-operated rats in which no tightening of the coronary sutures was
performed; group 2 (n10), rats pretreated with saline and subjected to 30
minutes of ischemia followed by 60 minutes of reperfusion; group 3
(n10), rats pretreated with the MAO inhibitor pargyline (10 mg/kg) 30
minutes before ischemia and subjected to 30 minutes of ischemia followed
by 60 minutes of reperfusion; group 4 (n10), rats treated under the same
conditions as group 3 but with the MAO-A inhibitor clorgyline (5 mg/kg);
group 5 (n6), rats pretreated for 3 days with the 5-HT2BR antagonist SB
206553 (1 mg · kg1 · d1; the first dose injected subcutaneously, the
following doses given in the drinking water, as reported previously)20 and
then treated with pargyline (10 mg/kg) 30 minutes before ischemia and
subjected to 30 minutes of ischemia followed by 60 minutes of reperfusion;
group 6 (n6), rats treated under the same conditions as group 5 but with
the MAO-A inhibitor clorgyline (5 mg/kg) instead of pargyline; group 7
(n6), rats subjected to 30 minutes of ischemia followed by 60 minutes of
reperfusion treated with pargyline (10 mg/kg) 20 minutes after induction of
ischemia; and group 8 (n6), rats treated under the same conditions as
group 7 but with the MAO-A inhibitor clorgyline (5 mg/kg) instead of
pargyline. Saline, pargyline, and clorgyline injections were carried out
through the dorsal penile vein.
Determination of Area at Risk and Infarct Size
After 60 minutes of reperfusion, in some animals of each group, the
left anterior descending coronary artery was reoccluded, and 1 mL of
1% Evans blue dye was injected into the carotid artery. Right
ventricular and atrial tissues were removed, and heart was sliced
Figure 1. Effect of 5-HT on apoptosis and
caspase-3 activation in rat cardiomyocytes.
Cell nuclei were double stained with
SYTO-13 and propidium iodide, discriminat-
ing normal cells from cells undergoing apo-
ptosis (arrow) or necrosis by fluorescence
microscopy. A, Photomicrographs of cardio-
myocytes pretreated for 30 minutes with or
without 1 mol/L pargyline, 50 mol/L defer-
oxamine, 1 mol/L pyruvate, 25 mol/L
5-HT transporter blocker imipramine, or 1
mol/L 5HT2B receptor antagonist SB
206553 before addition of 5-HT (10 mol/L)
for 24 hours. B, Quantification of cardiomyo-
cytes stained with SYTO-13 and propidium
iodide. Percentage of apoptotic and necrotic
cells presented in A. Data result from count-
ing 3 fields of 100 cells each per dish. Val-
ues are meanSEM of the percentage of
morphologically apoptotic and necrotic cells
from three separate experiments. C,
Caspase-3 activity was measured fluoro-
metrically with 20 mol/L Ac-DEVD-AMC as
described in Methods. Data are meanSEM
from 3 independent experiments. ***P0.001
vs control, ###P0.001 vs 10 mol/L 5-HT
alone.
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transversely (12 to 13 slices) and immersed in a 1% solution of
2,3,5-triphenyltetrazolium chloride (TTC) for 20 minutes. The left
ventricular sections were fixed in 10% formalin for 24 hours,
weighed, and visualized under an Olympus microscope equipped
with a closed-circuit television camera (Sony). In each photograph,
the area at risk (unstained by Evans blue dye) and the infarcted area
(unstained by TTC) were outlined and measured by planimetry. The
mass of tissue in each region was calculated using the areas
measured in each slice and the wet weight of each slice. Infarct size
was expressed as a percentage of the area at risk (Table 1).
Morphology
Cardiac tissues were fixed in cold 4% glutaraldehyde in 0.1 mol/L sodium
cacodylate buffer, pH 7.4, for 3 hours at room temperature and were
postfixed in 1% osmium tetroxide in 0.1 mol/L phosphate buffer, pH 7.4,
for 1 hour at 4°C. Semithin sections (2m) were cut, stained with toluidine
blue sodium tetraborate, and studied by light microscopy. Electron micro-
scopic examination was carried out on ultrathin sections stained with uranyl
acetate and alkaline bismuth subnitrate and viewed under a Jeol 1010
electron microscope at 80 kV. In each fragment, 2 series of 6 to 8 ultrathin
sections cut at 2 different levels were examined and photographed (Table 2).
Myocyte and microvascular endothelium injury was quantified from elec-
tron micrographs (magnifications ranging from 3000 to 20 000).
Evaluation of Myeloperoxidase Activity
Myeloperoxidase (MPO) activity, a marker for neutrophil accumu-
lation, was evaluated according to the method of Bradley et al.21
Frozen samples of left ventricular tissue (100 mg) were homogenized
in 5 mmol/L potassium phosphate buffer and then centrifuged at
30 000g for 30 minutes at 4°C before extraction. The resulting
pellets were used to measure MPO activity after suspension in
50 mmol/L phosphate buffer containing 0.5% hexadecyltrimethyl
ammonium bromide. The pellets were centrifuged at 40 000g for 15
minutes; 0.2 mL supernatant specimen was added to 0.8 mL
50 mmol/L potassium phosphate buffer (pH 6.0) containing 0.167
mg/mL o-dianisidine dihydrochloride and 0.0005% H2O2. Absor-
bance was measured spectrophotometrically at 460-nm wavelength
for 2 minutes. MPO activity, normalized to the protein content of the
supernatant, was expressed as milliunit per milligram of protein.
Determination of Malondialdehyde Production
Malondialdehyde (MDA), an end product of lipid peroxidation, was
determined by measurement of the chromogen generated from the reaction
of MDA with 2-thiobarbituric acid as described previously.22 The cardiac
tissues were placed in 50 mmol/L Tris-HCl (pH 7.4) containing
180 mmol/L KCl and 10 mmol/L EDTA in a total volume of 2 mL and
homogenized. Briefly, 0.02 mol/L HCl and 0.4% thiobarbituric acid were
added to the homogenates and heated to 95°C for 20 minutes. After the
addition of 2 mL of 1-butanol, the mixture was centrifuged at 2000 rpm for
10 minutes at 4°C. Absorbance of the upper layer was read spectrophoto-
metrically at 548-nm wavelength. Results are expressed as nanomole of
MDA per milligram of protein.
Figure 2. Effect of 5-HT on Bax/Bcl-2 expression and cytochrome c release in cardiomyocytes. Cardiac myocytes were pretreated for
30 minutes with or without 1 mol/L pargyline, 50 mol/L deferoxamine, 1 mol/L pyruvate, or 25 mol/L imipramine before the addi-
tion of 5-HT (10 mol/L) for 16 hours. The expression of Bax (A) and Bcl-2 (B) proteins and the intracellular distribution of cytochrome
c (C) were determined by Western blot in cell lysates (left). Ponceau red was used to confirm equal loading of the extracts. Right,
Quantification of Western blot data. Results are meanSEM from 3 independent experiments. **P0.01, ***P0.001 vs control.
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Statistical Analysis
Data are given as meanSEM. The ANOVA procedure, followed by
Student-Newman-Keuls multiple comparison test or Student’s t test,
was used for statistical comparison as appropriate (GraphPad Soft-
ware). A value of P0.05 was considered statistically significant.
Results
Serotonin-Dependent Cardiac Cell Death
Treatment of cardiac myocytes with 5-HT for 24 hours induced a
significant increase in SYTO-13 cell labeling (35% versus control;
P0.001) and caspase-3 activity (2.5-fold versus control; P0.01)
with a maximal effect at 10 mol/L (Figure 1B and 1C). Higher
5-HT concentrations (50 to 100 mol/L) resulted in both apoptotic
and necrotic cell death (Figure 1B). The apoptotic effect of 5-HT
was associated with mitochondrial dysfunction. Indeed, as shown in
Figure 2, cardiomyocytes incubated with 5-HT displayed a signif-
icant increase in the expression of the proapoptotic protein Bax. The
increase in Bax was concomitant with a decrease in the expression
of the antiapoptotic protein Bcl-2. Analysis of cytochrome c
distribution showed that the alteration of Bax and Bcl-2 expression
was followed by release of cytochrome c from mitochondria and its
accumulation in the cytosol (Figure 2). Cardiomyocyte apoptosis by
5-HT was concomitant with intracellular oxidative stress and H2O2
generation (Figure 3). Indeed, we showed that 5-HT induced a
decrease in the intracellular GSH/GSSG ratio (Figure 3A). In
addition, 5-HT (10 to 100 mol/L) also induced dependent intra-
cellular H2O2 formation (Figure 3B), as measured with the fluores-
cent probe DCF.
Serotonin effects on SYTO-13 labeling, caspase-3 activity, Bax
increase, Bcl-2 decrease, cytochrome c redistribution, and oxidative
stress production were fully prevented by cardiomyocyte treatment
with the MAO inhibitor pargyline, the amine transporter inhibitor
imipramine, the iron chelator deferoxamine, or the antioxidant
pyruvate. In contrast, the increase in 5-HT–dependent cardiomyo-
cyte apoptosis was unaffected by cell pretreatment with the 5-HT2B
receptor antagonist SB 206553. Taken together, these data show
that 5-HT induces cardiomyocyte apoptosis by a mechanism in-
volving H2O2 generation by MAO-A.
Involvement of MAOs in the Postreperfusion
Cardiac Damage
To determine the relevance of H2O2 production by MAOs in vivo,
we investigated the effects of MAO inhibition in cardiac damage
after I/R. Figure 4 shows the effect of MAO inhibition on myocar-
dial infarct size of rats subjected to 30 minutes of myocardial
ischemia and 60 minutes of reperfusion with or without pretreat-
ment with MAO inhibitors (pargyline and clorgyline). The area at
risk is not modified by the different treatments (Table 1). Infarct size
is significantly reduced in animals treated with pargyline or clorgy-
line compared with saline-treated ischemic rats. Rat pretreatment
with the 5-HT2B receptor antagonist SB 206553 for 3 days did not
reverse the effect of the MAO inhibitors (Figure 4 and Table 1),
indicating that the cardioprotective properties of pargyline and
clorgyline were not due to 5-HT receptor activation. On the other
hand, MAO inhibitors also induced cardioprotection when given 20
minutes after the onset of ischemia (infarct size, 57.35.9% in the
Figure 3. Effect of 5-HT on GSH/GSSG content and H2O2 pro-
duction in rat cardiomyocytes. A, Oxidative stress was assessed
by measuring the GSH/GSSG ratio after cardiomyocyte treat-
ment with 10 mol/L 5-HT for 16 hours in the absence or pres-
ence of 1 mol/L pargyline, 1 mol/L pyruvate, or 50 mol/L
deferoxamine. B, Effect of 5-HT on H2O2 production (DCF fluo-
rescence) in the presence or absence of pargyline (1 mol/L).
Data are meanSEM from 3 independent experiments.
***P0.001 vs control; ###P0.001 vs pargyline treatment.
Figure 4. Effects of MAO inhibitors on postreperfusion myocardial
injury. Infarct size is expressed as percentage of area at risk. Ani-
mal groups are described in Methods. Data are expressed as
meanSEM from 8 separate experiments. Sham indicates sham-
operated rats treated with saline; I/R, rats subjected to 30 minutes
of ischemia followed by 60 minutes of reperfusion; PI/R and
CI/R, rats treated before ischemia with pargyline or clorgyline,
respectively; and PSBI/R and CSBI/R, rats treated before
ischemia with pargyline and SB 206553 or clorgyline and SB
206553, respectively. ***P0.001 vs I/R group.
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I/R animals and 26.23.6% in the pargyline-treated I/R animals,
P0.01; 31.74.3% in clorgyline-treated I/R animals, P0.01).
Light microscopic analysis of postischemic semithin sections
demonstrated attenuated myofibril hypercontraction and interstitial
edema in pargyline-treated rats (Figure 5A). In addition, ultrastruc-
tural cell lesions induced by myocardial ischemia were detected by
electron microscopy. Indeed, quantification of ultrastructural tissue
damage (Table 2) revealed that myocyte injury was significantly
increased in the I/R hearts (sham-operated, 0.30.2; I/R, 2.80.1;
P0.001) and was largely prevented in pargyline-treated rats (I/R,
2.80.1; pargylineI/R, 1.30.3; P0.01). Similarly, endothelial
cell damage was significantly increased in the I/R hearts (sham-
operated, 0.20.1; ischemic-reperfused, 2.90.1; P0.001) and
was strongly reduced by pargyline treatment (I/R, 2.90.1;
pargylineI/R, 10.2; P0.001).
Effect of MAO Inhibition on Lipid Peroxidation
and Phagocyte Infiltration
Oxidative stress and phagocyte infiltration have been proposed a
key mediators triggering postreperfusion cardiac damage.23 As
shown in Figure 6, MDA levels (Figure 6A) and MPO activity
(Figure 6B), markers of lipid peroxidation and infiltration of
ROS-generating inflammatory cells (ie, neutrophils and macro-
phages), respectively, were increased after 1 hour of reperfusion in
ventricules from saline-treated rats compared with sham-operated
animals. Treatment with the MAO inhibitor pargyline or the
MAO-A inhibitor clorgyline resulted in a significant reduction in
myocardial MDA levels and MPO activity compared with un-
treated I/R animals.
Cardiac Cell Apoptosis, Bax and Bcl-2 Expression,
and Procaspase-3 Cleavage
Finally, to determine whether MAO-dependent ROS production
may contribute to postreperfusion cardiomyocyte apoptosis, we
examined the effects of pargyline on TUNEL staining, Bax/Bcl-2
balance, and procaspase-3 cleavage. As shown in Figure 7A and
7B, I/R induced a significant increase in the number of TUNEL-
positive cells compared with sham-operated animals. This effect
was strongly prevented by rat treatment with pargyline or clorgy-
line. I/R also increases the expression of the proapoptotic protein
Bax, decreases the expression of the antiapoptotic protein Bcl-2, and
induces procaspase-3 cleavage (Figure 7C and 7D). In rats treated
with pargyline, the amounts of Bax, Bcl-2, and procaspase-3 were
similar to those found in sham-operated animals.
Discussion
The major finding of this study is the demonstration that 5-HT
behaves as a proapoptotic factor in cardiomyocytes and that its
effect occurs independently of receptor stimulation. The novel
mechanism of action of 5-HT that we describe requires 5-HT
uptake into cardiac cells, its degradation by MAO-A, and H2O2
production. In addition, we demonstrate that H2O2 production by
MAO-A plays a critical role in post-I/R events leading to cardiac
damage.
The demonstration that 5-HT is able to regulate directly cardio-
myocyte functions is relatively recent. As reported in a variety of
cell types,24–26 5-HT displays trophic and protective properties in
cardiac cells. Via 5-HT2B receptors, 5-HT induces cardiac hypertro-
phy27 and prevents cardiomyocytes from apoptosis.3 The 5-HT2B
receptor–mediated antiapoptotic effect of 5-HT involves inhibition
Figure 5. Representative light (A) and
electron (B) micrographs of the left ven-
tricle from sham-operated and I/R rats
treated with saline or pargyline. A, Tolu-
idine blue–stained sections showing
myofibril hypercontraction and interstitial
edema in rats subjected to 30 minutes of
ischemia followed by 60 minutes of
reperfusion (I/R) vs sham-operated
(Sham) or pargyline treated
(PargylineI/R) rats. Bar100 m. B,
Cardiomyocytes from sham-operated
rats (a) contain myofibrils with prominent
cross banding and mitochondria rich in
cristae; an endothelial cell from a blood
capillary (asterisk) shows thin cytoplasm
rich in pinocytosis vesicles. Myocardial
tissue from rats subjected to I/R showed
myofibril hypercontraction and interstitial
edema (b), myofibril disarrangement (*)
and mitochondrial swelling within a
severely injured cardiomyocyte (c), swol-
len cytoplasm (arrows), and reduction of
pinocytotic vesicles in endothelial cell (d).
Myocardial tissue from pargyline-treated
rats displays cardiomyocytes with non-
damaged myofibrils and mitochondria (e)
and blood capillaries with normal endo-
thelial cells (f). Bar1 m.
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of the mitochondrial apoptotic machinery via cross-talks between
the ERK and Akt pathways. Our results show for the first time that
5-HT may also promote cardiomyocyte apoptosis. This effect
occurs at concentrations (10mol/L) higher than those observed for
the antiapoptotic activity (1mol/L). In contrast to that observed for
the antiapoptotic properties of 5-HT, cell apoptosis by 5-HT does
not require receptor stimulation. Indeed, we showed that the
increase in cardiomyocyte apoptosis by 5-HT was unaffected by
cell treatment with the 5-HT2B receptor antagonist SB 206553 and
was completely prevented by the amine transporter inhibitor imip-
ramine. The effect of 5-HT involves the activation of the mitochon-
drial proapoptotic pathway as shown by the release of cytochrome
c, upregulation of the proapoptotic Bax protein, and downregulation
of the antiapoptotic Bcl-2 protein. Taken together, our results and
those previously reported by Nebigil and coworkers3 suggest that,
depending on the concentrations and the mechanisms of action,
5-HT may have opposite effects on cardiomyocyte survival. It is
conceivable that, in vivo, these dual concentration-dependent effects
of 5-HT may contribute in different ways to the initiation and
progression of ventricular dysfunction.
We showed that the receptor-independent apoptotic effects of
5-HT in cardiac cells requires ROS production. Various sources of
ROS, including mitochondrial electron-transport chain, arachidonic
acid metabolism, and nonphagocyte NADPH oxidase, have been
proposed to mediate cell apoptosis in the heart in response to
different agents.28 Concerning serotonin, we have identified the
mitochondrial enzyme MAO-A as the intracellular source of ROS
involved in cardiomyocyte apoptosis. During the oxidative deami-
nation of serotonin, this enzyme generates H2O2, which can be
inactivated by antioxidants or, in the presence of iron, converted to
hydroxyl radical by the Fenton reaction. At the concentrations
leading to cardiomyocyte apoptosis, we showed that serotonin
induces H2O2 generation and intracellular oxidative stress, which
were prevented by MAO inhibition, antioxidant, or iron chelation.
The localization of MAO-A within the outer mitochondrial mem-
brane and ROS production in mitochondrial environment may be
particularly relevant for triggering mitochondrial dysfunction asso-
ciated with apoptotic cell death. This possibility is supported by
previous findings showing that treatment of isolated mitochondria
from brain with the MAO substrate tyramine induced a decrease in
mitochondrial respiration concomitant with glutathion oxidation.29
According to these results, we showed that MAO-dependent ROS
generation induced an increase in the Bax/Bcl-2 ratio and mitochon-
drial cytochrome c release, leading to cardiac cell apoptosis. These
findings point out the critical role of ROS produced by MAO-A
during serotonin degradation in triggering the proapoptotic mito-
chondrial cascade.
Oxidative stress and mitochondrial dysfunction are considered
key mediators of cardiomyocyte apoptosis associated with post-I/R
cardiac damage.28 In addition, large amounts of serotonin are
released by activated platelets during vascular injury30 and I/R.5 It is
noteworthy that the 5-HT concentration inducing cardiomyocyte
apoptosis in vitro (10 mol/L) is compatible with those potentially
observed in vivo. Indeed, it has been shown that, in cats5 and mice,1
platelets can release up to 27-mol/L concentrations of 5-HT. In
addition, Fu and Longhurts5 have recently shown that large amounts
of 5-HT (5mol/L) can be released by activated platelets in cardiac
venous blood after I/R in cats. From these observations, we
investigated the potential role of MAO-A in oxidative stress and
cardiac damage in a rat model of cardiac I/R.
In our in vitro studies, we showed that the 5-HT–degrading
enzyme MAO-A participates in the induction of the cardiomyocyte
damage after I/R. Indeed, we demonstrated that rat pretreatment
with the irreversible MAO-A/B inhibitor pargyline or the selective
MAO-A inhibitor clorgyline significantly reduced infarct size. This
effect was not reversed by the 5-HT2B receptor antagonist SB
206553, indicating that the increase in cardiac 5-HT that may follow
MAO inhibition is not responsible for cardiac protection. These
findings are in agreement with previous results indicating that
stimulation of 5-HT receptors is involved in postreperfusion cardiac
damage rather than cardioprotection.6,31,32 Interestingly, MAO in-
hibitors also decreased cardiac damage after I/R when administered
10 minutes before reperfusion. These results suggest that MAO
inhibitors may have clinical relevance for the prevention of postre-
perfusion cardiac injury by treating patients in the period occurring
between the ischemic event and reperfusion.
Electron microscopic study of postischemic rat hearts showed
that MAO inhibition prevented ultrastructural abnormalities, includ-
ing myofibril hypercontraction, interstitial edema, and mitochon-
drial swelling. The cardioprotective effects of MAO inhibition were
associated with a significant reduction of postreperfusion oxidative
stress. We found that MAO inhibition also prevented cardiac
accumulation of ROS-generating phagocytes. These results are in
Figure 6. Effect of MAO inhibition on myocardial postreperfusion
lipid peroxidation MDA (A) and MPO (B) activity. Sham indicates
sham-operated rats treated with saline; I/R, rats subjected to
ischemia followed by reperfusion; and PI/R and CI/R, rats
treated before ischemia with pargyline or clorgyline, respec-
tively. Data are expressed as meanSEM from 8 separate
experiments. **P0.01 and ***P0.001 vs sham-operated
group; #P0.05 vs I/R group.
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agreement with previous reports suggesting that an initial burst of
ROS at the onset of reperfusion may participate in delayed ROS
generation by phagocytes.23 Prevention of postreperfusion cardiac
damage and oxidative stress by MAO inhibition was associated
with a decrease in caspase activation, upregulation of Bax, and
downregulation of Bcl-2. Taken together, these results show that
MAO-A is a major source of ROS-triggered myocardial apoptosis
after reperfusion.
In conclusion, the identification of a new MAO-dependent
mechanism involved in the 5-HT–triggered cardiomyocyte apopto-
sis opens new perspectives for the comprehension of the role of this
biogenic amine in the heart. It is conceivable that the serotonin-
MAO pathway may play a role not only in post-I/R syndrome but
also in other heart diseases associated with cardiomyocyte apopto-
sis. Additional studies are necessary to verify this possibility and to
define the potentiality of MAO-A as a pharmacological target for
the prevention and therapy of cardiac diseases.
Acknowledgments
This work was supported by the Institut National de la Santé et de la
Recherche Médicale France and by a grant from the University of
Florence (Italy). Drs Bianchi and Kunduzova were supported by a
postdoctoral fellowship from the Fondation pour la Recherche
Médicale. We would like to thank XinXin Guo and Kara Clemente
for their technical support.
References
1. Cote F, Thevenot E, Fligny C, Fromes Y, Darmon M, Ripoche MA,
Bayard E, Hanoun N, Saurini F, Lechat P, Dandolo L, Hamon M, Mallet
J, Vodjdani G. Disruption of the nonneuronal tph1 gene demonstrates the
importance of peripheral serotonin in cardiac function. Proc Natl Acad
Sci U S A. 2003;100:13525–13530.
2. Pino R, Cerbai E, Calamai G, Alajmo F, Borgioli A, Braconi L, Cassai M,
Montesi GF, Mugelli A. Effect of 5-HT4 receptor stimulation on the pacemaker
current I(f) in human isolated atrial myocytes. Cardiovasc Res. 1998;40:
516–522.
3. Nebigil CG, Etienne N, Messaddeq N, Maroteaux L. Serotonin is a novel survival
factor of cardiomyocytes: mitochondria as a target of 5-HT2B receptor signaling.
FASEB J. 2003;17:1373–1375.
Figure 7. Effect of MAO inhibition on myocardial cell death, Bax/Bcl-2 expression, and procaspase-3 cleavage. A, B, Apoptosis was
evaluated by TUNEL staining heart sections as describe in Methods. A, Light photomicrographs (magnification 40) of heart sections.
Bright green dots correspond to TUNEL-positive nucleus. B, Percentage of TUNEL-positive cells in heart sections of A. Data are
expressed as meanSEM from 4 separate experiments quantified in triplicate. C, Western blot analysis of Bax, Bcl-2, and
procaspase-3 expression. D, Quantification of Western blot analysis of Bax, Bcl-2, and procaspase-3 expression. Data are expressed
as meanSEM from 4 separate experiments. Sham indicates sham-operated rats treated with saline; I/R, rats subjected to ischemia
followed by reperfusion; PI/R, rats treated with pargyline before ischemia; and CI/R, rats treated with clorgyline before ischemia.
**P0.01 vs sham-operated group; ***P0.001 vs sham-operated group.
3304 Circulation November 22, 2005
 at UNIV DI FIRENZE on February 27, 2012http://circ.ahajournals.org/Downloaded from 
4. Moller JE, Connolly HM, Rubin J, Seward JB, Modesto K, Pellikka PA. Factors
associated with progression of carcinoid heart disease. N Engl J Med. 2003;348:
1005–1015.
5. Fu LW, Longhurst JC. Activated platelets contribute to stimulation of cardiac
afferents during ischaemia in cats: role of 5-HT(3) receptors. J Physiol. 2002;
544:897–912.
6. Shimizu Y, Minatoguchi S, Hashimoto K, Uno Y, Arai M, Wang N, Chen X, Lu
C, Takemura G, Shimomura M, Fujiwara T, Fujiwara H. The role of serotonin in
ischemic cellular damage and the infarct size-reducing effect of sarpogrelate, a
5-hydroxytryptamine-2 receptor blocker, in rabbit hearts. J Am Coll Cardiol.
2002;40:1347–1355.
7. Longhurst JC, Tjen ALSC, Fu LW. Cardiac sympathetic afferent activation
provoked by myocardial ischemia and reperfusion: mechanisms and reflexes.
Ann NY Acad Sci. 2001;940:74–95.
8. Metais C, Bianchi C, Li J, Simons M, Sellke FW. Serotonin-induced human
coronary microvascular contraction during acute myocardial ischemia is blocked
by COX-2 inhibition. Basic Res Cardiol. 2001;96:59–67.
9. Tjen ALSC, Fu LW, Longhurst JC. Xanthine oxidase, but not neutrophils,
contributes to activation of cardiac sympathetic afferents during myocardial
ischaemia in cats. J Physiol. 2002;543:327–336.
10. Maurel A, Hernandez C, Kunduzova O, Bompart G, Cambon C, Parini A,
Frances B. Age-dependent increase in hydrogen peroxide production by cardiac
monoamine oxidase A in rats. Am J Physiol Heart Circ Physiol. 2003;284:
H1460–H1467.
11. Chen K. Organization of MAO-A and MAO B promoters and regulation of gene
expression. Neurotoxicology. 2004;25:31–36.
12. Weyler W, Hsu YP, Breakefield XO. Biochemistry and genetics of monoamine
oxidase. Pharmacol Ther. 1990;47:391–417.
13. Bianchi P, Seguelas MH, Parini A, Cambon C. Activation of pro-apoptotic
cascade by dopamine in renal epithelial cells is fully dependent on hydrogen
peroxide generation by monoamine oxidases. J Am Soc Nephrol. 2003;14:
855–862.
14. Tiago Guimaraes J, Soares-da-Silva P. Unusual pattern of beta-phenylethylamine
deamination in the rat heart. Neurobiology (Bp). 2000;8:109–118.
15. Raasch W, Bartels T, Gieselberg A, Dendorfer A, Dominiak P. Angiotensin
I-converting enzyme inhibition increases cardiac catecholamine content and
reduces monoamine oxidase activity via an angiotensin type 1 receptor-mediated
mechanism. J Pharmacol Exp Ther. 2002;300:428–434.
16. Lamontagne D, Yamaguchi N, Ribuot C, de Champlain J, Nadeau R. Reduction
of tissue noradrenaline content in the isolated perfused rat heart during ischemia:
importance of monoamine oxidation. Can J Physiol Pharmacol. 1991;69:
1190–1195.
17. Calderone A, Takahashi N, Izzo NJ Jr, Thaik CM, Colucci WS. Pressure- and
volume-induced left ventricular hypertrophies are associated with distinct
myocyte phenotypes and differential induction of peptide growth factor mRNAs.
Circulation. 1995;92:2385–2390.
18. Ellingsen O, Davidoff AJ, Prasad SK, Berger HJ, Springhorn JP, Marsh JD, Kelly
RA, Smith TW. Adult rat ventricular myocytes cultured in defined medium:
phenotype and electromechanical function. Am J Physiol. 1993;265:H747–H754.
19. Meilhac O, Escargueil-Blanc I, Thiers JC, Salvayre R, Negre-Salvayre A. Bcl-2
alters the balance between apoptosis and necrosis, but does not prevent cell death
induced by oxidized low density lipoproteins. FASEB J. 1999;13:485–494.
20. Jaffre F, Callebert J, Sarre A, Etienne N, Nebigil CG, Launay JM, Maroteaux L,
Monassier L. Involvement of the serotonin 5-HT2B receptor in cardiac hyper-
trophy linked to sympathetic stimulation: control of interleukin-6, interleukin-1,
and tumor necrosis factor- cytokine production by ventricular fibroblasts. Cir-
culation. 2004;110:969–974.
21. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of
cutaneous inflammation: estimation of neutrophil content with an enzyme
marker. J Invest Dermatol. 1982;78:206–209.
22. Aruoma OI, Halliwell B, Laughton MJ, Quinlan GJ, Gutteridge JM. The
mechanism of initiation of lipid peroxidation. Evidence against a requirement for
an iron(II)-iron(III) complex. Biochem J. 1989;258:617–620.
23. Zhao ZQ. Oxidative stress-elicited myocardial apoptosis during reperfusion. Curr
Opin Pharmacol. 2004;4:159–165.
24. Greene EL, Houghton O, Collinsworth G, Garnovskaya MN, Nagai T, Sajjad T,
Bheemanathini V, Grewal JS, Paul RV, Raymond JR. 5-HT(2A) receptors
stimulate mitogen-activated protein kinase via H(2)O(2) generation in rat renal
mesangial cells. Am J Physiol Renal Physiol. 2000;278:F650–F658.
25. Lee SL, Simon AR, Wang WW, Fanburg BL. H(2)O(2) signals 5-HT-induced
ERK MAP kinase activation and mitogenesis of smooth muscle cells.
Am J Physiol Lung Cell Mol Physiol. 2001;281:L646–L652.
26. Pizzinat N, Girolami JP, Parini A, Pecher C, Ordener C. Serotonin metabolism in
rat mesangial cells: involvement of a serotonin transporter and monoamine
oxidase A. Kidney Int. 1999;56:1391–1399.
27. Nebigil CG, Jaffre F, Messaddeq N, Hickel P, Monassier L, Launay JM,
Maroteaux L. Overexpression of the serotonin 5-HT2B receptor in heart leads to
abnormal mitochondrial function and cardiac hypertrophy. Circulation. 2003;
107:3223–3229.
28. Kumar D, Jugdutt BI. Apoptosis and oxidants in the heart. J Lab Clin Med.
2003;142:288–297.
29. Cohen G, Farooqui R, Kesler N. Parkinson disease: a new link between
monoamine oxidase and mitochondrial electron flow. Proc Natl Acad Sci U S A.
1997;94:4890–4894.
30. Vikenes K, Farstad M, Nordrehaug JE. Serotonin is associated with coronary
artery disease and cardiac events. Circulation. 1999;100:483–489.
31. Takano S, Hoshino Y, Li L, Matsuoka I, Ono T, Kimura J. Dual roles of
5-hydroxytryptamine in ischemia-reperfusion injury in isolated rat hearts. J Car-
diovasc Pharmacol Ther. 2004;9:43–50.
32. Temsah RM, Kumamoto H, Takeda N, Dhalla NS. Sarpogrelate diminishes
changes in energy stores and ultrastructure of the ischemic-reperfused rat heart.
Can J Physiol Pharmacol. 2001;79:761–767.
CLINICAL PERSPECTIVE
In the heart, serotonin has been involved in the regulation of normal cardiac development and in different diseases,
including arrhythmias, ventricular hypertrophy, and cardiac valvular insufficiency associated with carcinoid tumors.
Recently, several studies showed that serotonin, released by activated platelets, accumulates in the heart during I/R and
contributes to the progression of myocardial injury and dysfunction. The availability of cardiac serotonin depends on the
activity of the MAO-A. During serotonin degradation, MAO-A produces large amounts of H2O2. The major findings of this
study are that serotonin behaves as a proapoptotic factor in cardiomyocytes and that its effect occurs independently of
serotonin receptor stimulation. The novel mechanism of action of serotonin that we describe requires serotonin uptake into
cardiac cells, its degradation by MAO-A, and H2O2 production. In addition, we demonstrate that H2O2 production by
MAO-A plays a critical role in post-I/R apoptosis, leading to cardiac damage. The identification of a new MAO-dependent
mechanism involved in the serotonin-triggered cardiomyocyte apoptosis offers new perspectives for the role of this
biogenic amine in the heart. It is conceivable that the serotonin-MAO pathway may represent a potential pharmacological
target for the prevention and therapy not only of cardiac I/R but also of other heart diseases associated with cardiomyocyte
apoptosis.
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